Alcohol Abstinence
Treatment for Alcoholic cardiomyopathy
Typical Dosage: complete cessation
Effectiveness
95%
Safety Score
100%
Clinical Trials
0
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
100
DangerousModerateSafe
Treatment Details
Dosage Range
complete cessation
Time to Effect
3-6 months
Treatment Duration
lifetime
Evidence Quality
HIGHConfidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$2,000
Total Annual:$2,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
2
Outcome-Based Costs
Cost per Responder
$4,167
Cost per Remission
$10,000
Alcohol Abstinence Outcomes
for Alcoholic cardiomyopathy
Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+60%
Remission Rate
+25%
Common Side Effects
Alcohol withdrawal syndrome
+50%
Delirium tremens
+5%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov